Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

Routine eye exams may be needed for alopecia areata patients due to common eye issues.

People with Alopecia Areata are more likely to have autoimmune diseases, inflammatory diseases, and mental health issues like anxiety and depression.

New treatments for alopecia areata show promise but need ongoing use and have infection risks.

Hejie Shengfa Decoction may help treat alopecia areata by promoting hair growth and reducing inflammation, but more safety studies are needed.

The guideline recommends personalized treatment for alopecia areata, including new oral medications and psychological support.

A personalized treatment combining traditional and new therapies may improve hair loss outcomes in alopecia areata.

Triamcinolone is more effective than methotrexate for treating localized alopecia areata.

Vitamin D deficiency is common in children with and without alopecia areata, and more research is needed.

hsa-miR-193a-5p may help diagnose and treat alopecia areata.

High CRP levels could indicate vitamin D deficiency in people with alopecia areata.

Oral tofacitinib may be an effective future treatment for children with severe alopecia areata, but more research is needed.

JAK inhibitors, PRP, and exosomes show promise for hair regrowth in Alopecia Areata.

Pentoxifylline is a safe and effective alternative to triamcinolone acetonide for treating localized alopecia areata.

Intralesional triamcinolone acetonide is better than PRP for treating scalp alopecia areata, leading to faster and more complete hair regrowth.

Alopecia areata significantly impacts patients' mental health and quality of life.

Low vitamin D levels are linked to severe and active alopecia areata.

Oral cyclosporine works better than betamethasone minipulse therapy for treating Alopecia Areata.

DM and AA may share a common cause.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

Crossbreeding improves goat fiber quality, and specific genes affect hair traits and color.

Phosphorus homeopathy treatment led to complete hair regrowth in two Alopecia Areata patients.

Alopecia areata in children is more common in boys, mainly affects the scalp, and is linked to genetics and psoriasis.

Methotrexate is a promising and safe treatment for severe alopecia areata, with better results when combined with corticosteroids.

Diphencyprone (DPC) is an effective and safe long-term treatment for alopecia areata, especially with maintenance therapy.

Dexamethasone mini-pulse therapy is effective for alopecia areata but less effective for those with early onset or hypothyroidism.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Wigs help improve self-esteem and quality of life for people with hair loss from alopecia areata.

Mesenchymal stem cells may help treat hair loss by improving hair cell growth and reducing inflammation.